US Stock MarketDetailed Quotes
OCGN Ocugen
- 0.9821
- +0.0123+1.27%
Close Nov 29 13:00 ET
- 0.9800
- -0.0021-0.21%
Post 16:53 ET
286.11MMarket Cap-5168P/E (TTM)
1.0200High0.9700Low2.27MVolume0.9700Open0.9698Pre Close2.26MTurnover0.79%Turnover RatioLossP/E (Static)291.32MShares2.105052wk High7.07P/B282.20MFloat Cap0.360052wk Low--Dividend TTM287.34MShs Float778.1999Historical High--Div YieldTTM5.16%Amplitude0.1700Historical Low0.9960Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Ocugen Stock Forum
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet